These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19176691)

  • 1. A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model.
    Bentancor LV; Bilen M; Brando RJ; Ramos MV; Ferreira LC; Ghiringhelli PD; Palermo MS
    Clin Vaccine Immunol; 2009 May; 16(5):712-8. PubMed ID: 19176691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.
    Rojas RL; Gomes PA; Bentancor LV; Sbrogio-Almeida ME; Costa SO; Massis LM; Ferreira RC; Palermo MS; Ferreira LC
    Clin Vaccine Immunol; 2010 Apr; 17(4):529-36. PubMed ID: 20147499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice.
    Gu J; Liu Y; Yu S; Wang H; Wang Q; Yi Y; Zhu F; Yu XJ; Zou Q; Mao X
    Microbes Infect; 2009 Sep; 11(10-11):835-41. PubMed ID: 19427397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant hybrid peptide composed of AAF adhesin of enteroaggregative Escherichia coli and Shiga toxin B subunit elicits protective immune response in mice.
    Oloomi M; Bouzari S; Emami S
    Eur J Clin Microbiol Infect Dis; 2009 Nov; 28(11):1311-6. PubMed ID: 19655181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.
    Bentancor LV; Mejías MP; Pinto A; Bilen MF; Meiss R; Rodriguez-Galán MC; Baez N; Pedrotti LP; Goldstein J; Ghiringhelli PD; Palermo MS
    mBio; 2013 Oct; 4(5):e00501-13. PubMed ID: 24085779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B.
    Zhu C; Yu J; Yang Z; Davis K; Rios H; Wang B; Glenn G; Boedeker EC
    Clin Vaccine Immunol; 2008 Feb; 15(2):359-66. PubMed ID: 18003816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with a chimera consisting of the B subunit of Shiga toxin type 2 and brucella lumazine synthase confers total protection against Shiga toxins in mice.
    Mejias MP; Ghersi G; Craig PO; Panek CA; Bentancor LV; Baschkier A; Goldbaum FA; Zylberman V; Palermo MS
    J Immunol; 2013 Sep; 191(5):2403-11. PubMed ID: 23918978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of B subunit-specific monoclonal antibody clones that strongly neutralize the toxicity of Shiga toxin 2.
    Arimitsu H; Sasaki K; Iba Y; Kurosawa Y; Shimizu T; Tsuji T
    Microbiol Immunol; 2015 Feb; 59(2):71-81. PubMed ID: 25521016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera.
    Mejias MP; Cabrera G; Fernández-Brando RJ; Baschkier A; Ghersi G; Abrey-Recalde MJ; Miliwebsky E; Meiss R; Goldbaum F; Zylberman V; Rivas M; Palermo MS
    Infect Immun; 2014 Apr; 82(4):1491-9. PubMed ID: 24421050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against Vibrio cholerae, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein.
    Ghaffari Marandi BH; Zolfaghari MR; Kazemi R; Motamedi MJ; Amani J
    Microb Pathog; 2019 Sep; 134():103600. PubMed ID: 31202906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae.
    Sreerohini S; Balakrishna K; Parida M
    APMIS; 2019 Oct; 127(10):671-680. PubMed ID: 31344276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia.
    Marcato P; Griener TP; Mulvey GL; Armstrong GD
    Infect Immun; 2005 Oct; 73(10):6523-9. PubMed ID: 16177326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale preparation of Shiga toxin 2 in Escherichia coli for toxoid vaccine antigen production.
    Arimitsu H; Sasaki K; Shimizu T; Tsukamoto K; Shimizu T; Tsuji T
    Microbiol Immunol; 2013 Jan; 57(1):38-45. PubMed ID: 23157558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of DNA vaccines against hemolytic-uremic syndrome in a murine model.
    Capozzo AV; Pistone Creydt V; Dran G; Fernández G; Gómez S; Bentancor LV; Rubel C; Ibarra C; Isturiz M; Palermo MS
    Infect Immun; 2003 Jul; 71(7):3971-8. PubMed ID: 12819084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
    Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
    Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit.
    Marcato P; Mulvey G; Read RJ; Vander Helm K ; Nation PN; Armstrong GD
    J Infect Dis; 2001 Feb; 183(3):435-43. PubMed ID: 11133375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice.
    Gao X; Cai K; Li T; Wang Q; Hou X; Tian R; Liu H; Tu W; Xiao L; Fang L; Luo S; Liu Y; Wang H
    Vaccine; 2011 Sep; 29(38):6656-63. PubMed ID: 21742003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional capacity of Shiga-toxin promoter sequences in eukaryotic cells.
    Bentancor LV; Bilen MF; Mejías MP; Fernández-Brando RJ; Panek CA; Ramos MV; Fernández GC; Isturiz M; Ghiringhelli PD; Palermo MS
    PLoS One; 2013; 8(2):e57128. PubMed ID: 23451160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice.
    Gu J; Ning Y; Wang H; Xiao D; Tang B; Luo P; Cheng Y; Jiang M; Li N; Zou Q; Mao X
    Vaccine; 2011 Oct; 29(43):7395-403. PubMed ID: 21807051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.
    Mukherjee J; Chios K; Fishwild D; Hudson D; O'Donnell S; Rich SM; Donohue-Rolfe A; Tzipori S
    Infect Immun; 2002 Feb; 70(2):612-9. PubMed ID: 11796590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.